Professor Anne Wing-mui LEE

Prof Anne Wing-Mui LEE

Head of Department
Clinical Professor
Alice Ho Miu Ling Nethersole Charity Foundation Professor in Holistic Cancer Care
 

  • MBBS (HK), MD (HK), FRCR , FHKCR, FHKAM (Radiology)
Short Biography
Prof. Anne Lee is currently the Clinical Professor and Head, Department of Clinical Oncology, The University of Hong Kong. In addition, she is the Chief of Service for the Center of Clinical Oncology at The University of Hong Kong-Shenzhen Hospital in China, and the Chair of Specialty for Oncology at Gleneagles Hong Kong Hospital. She is also the Honorary Consultant, Departments of Clinical Oncology at Queen Mary Hospital and Pamela Youde Nethersole Eastern Hospital in Hong Kong.
Research Interests
Nasopharyngeal cancer
Selected Publications

• AWM Lee, B Ma, WT Ng, ATC Chan. The management of nasopharyngeal carcinoma – current practice and future perspective. JCO 2015.

• Pan JJ, Ng WT, Zong JF, Chan LLK, O’Sullivan B, Lin SJ, Sze HCK, Chen YB, Choi HCW, Guo QJ, Kan WK, Xiao YP, W Xu, Le QT, Glastonbury CM, Colevas AD, Weber RS, Shah JP, Lee AWM.* Proposal for the 8th Edition of AJCC/UICC Staging System for Nasopharyngeal Cancer in the Era of Intensity-Modulated Radiotherapy. Cancer DOI: 10.1002/cncr.29795 (2015).

• Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan ATC, Huang PY, Benhamou E, Zhu GP, Chua DTT, Chen Y, Mai HQ, Kwong DLW, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP, on behalf of the MAC-NPC Collaborative Group*. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 2015; 16: 645–55.

• Lee A,* Ngan R, Tung S, Cheng A, Kwong D, Lu TX, Chan A, Chan L, Yiu H, Ng WT, Wong F, Yuen KT, Yau S, Cheung FY, Chan O, Choi H, Chappell R. Preliminary Results of NPC-0501 Trial to Evaluate the Therapeutic Gain by Changing Chemoradiotherapy Sequence from Concurrent-Adjuvant to Induction-Concurrent, Fluorouracil to Capecitabine, and Radiotherapy Fractionation from Conventional to Accelerated for Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer, 121:1328-38; 2015.

• Brouwer CL, Steenbakkers RJHM, Bourhis J, Budach W, Grau C, Grégoire V, van Herk M, Lee A, Maingon P, Nutting C, O’Sullivan B, Porceddu SV, Rosenthal DI, Sijtsema NM, Langendijk JA. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol, 2015.

• Ng WT, Chang AT, Lee SW, Sze HC, Lee AW.* Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant. Curr Treat Options Oncol. Sep;16(9):361, 2015.

• Sze HCK, Blanchard P, Ng WT, Pignon JP, Lee AWM.* Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies. Hematology/Oncology Clinics of North America, 29:1107-1122; 2015.

• Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting CK, O’Sullivan B, Porceddum SV, Lengele B. Delineation of the Neck Node Levels for Head and Neck Tumors: A 2013 Update. DAHANCA, EORTC, HKNPCSF, NCIC, CTG, NCRI, RTOG, TROG Consensus Guidelines. Radiother Oncol, 110(1):172-181, 2014.

• Sun Y, Yu XL, Lee AWM, Wee JTS, Lee N Zhou GQ, Tang LL, Tao CJ, Guo R, Mao YP, Zhang R, Guo Y, Ma J. Recommendation for a Contouring Method and Atlas of Organs at Risk in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. Radiother Oncol, 110(3):390-397, 2014.

• Lee AWM,* Ng WT, Chan LLK, Hung WM, Chan CCC, Sze HCK, Chan OSH, Chang ATY, Yeung RM. Evolution of Treatment for Nasopharyngeal Cancer - Success and Setback in the Intensity-Modulated Radiotherapy Era. Radiother Oncol, 110(3):377-384, 2014.

• Lee AWM,* Sze H, Ng WT. Is Selective Neck Irradiation Safe for Node-Negative Nasopharyngeal Carcinoma? Int J Radiat Oncol Biol Phys, 85(4):902-903, 2013. • Lee AWM,* Ng WT, Chan YH, Sze H, Chan C, Lam TH. The Battle against Nasopharyngeal Cancer. Radiother Oncol, 104(3):272-278, 2012.

• Lee AWM,* Lin JC, Ng WT. Current Management of Nasopharyngeal Cancer. Seminar in Radiat Oncol, 22(3):233-244, 2012.

• Lee AWM,* Fee WE Jr, Ng WT, Chan LK. Nasopharyngeal Carcinoma: Salvage of Local Recurrence. Oral Oncol, 48(9):768-774, 2012.

• Lee AWM,* Tung SY, Chan ATC, Chappell R, Fu YT, Lu TX, Tan T, Chua DTT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, Tan EH, Au GKH, Siu L, Fung KK, Lau WH.A Randomized Trial on Addition of Concurrent-Adjuvant Chemotherapy and/or Accelerated Fractionation for Locally-Advanced Nasopharyngeal Carcinoma. Radiother Oncol, 98(1):15-22, 2011.

• Lee AWM,* Tung SY, Ngan RKC, Chappell R, Chua DTT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, Leung TW, Fu YT, Au GKH, Zhao C, O'Sullivan B, Tan EH, Lau WH. Factors Contributing to the Efficacy of Concurrent-Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: Combined Analyses of NPC-9901 And NPC-9902 Trials. Eu J Cancer, 47(5):656-666, 2011.

• Lee AWM,* Tung SY, Chua DTT, Ngan RKC, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GKH, Law SCK, O'Sullivan B, Yau TK, Leung TW, Au JSK, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH. Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma. J NCI,102(15):1188-1198, 2010.